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Abstract 
 
Background: Treatment understanding and experiences are vital to determine HIV patients’ adherence and retention to care. Methods: In-
depth patient interviews were audio-recorded, with a prior verbal and written consent and subjected to a thematic content analysis framework 
for data analysis. Results: Though majority of participants believed in Antiretroviral Therapy (ART) as the most effective way of treatment, 
they were greatly worried about its toxicities. Disease understanding and peer influence were regarded as the main reasons for treatment 
initiation; whereas, perceived side effects and lack of support system were among the main reasons associated with treatment delay. Almost 
all the patients experienced toxicities due to ARTs and viewed it negatively impacting their quality of life. Conclusion: It is vital for People 
Living with HIV/AIDS (PLWHA) to be retained in care; hence, the provision of optimal care with greater support to overcome treatment 
challenges must be focused in any HIV program. 
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INTRODUCTION 
 
Human immunodeficiency virus (HIV) has been causing 
infections among the human population, ever since 
HIV/AIDS was first recognised as a separate medical entity 
in 1981 [1], and without any doubts, the modern medical 
history may not have witnessed any similar disease or illness 
which is inter-connected to many aspects of the human life 
[2]. However, extraordinary efforts in all aspects of medical 
sciences and patient care have made it possible for HIV 
infection to be a chronic manageable disease [3]. While on the 
global agenda zero discrimination, 90:90:90 treatments for all 
and elimination of HIV by 2030 are on the top [4], it is the 
developing world facing considerable challenges in 
managing both the social and health impacts of the disease.  
 
With the shift of HIV as a chronic disease, it is imperative for 
the patient to remain on HIV treatment for an indefinite 
period [5]. This requires patients’ strict adherence to the 
antiretroviral therapy (ART); nonetheless, researches around 
the world have reported that antiretroviral medications cause 
both short-and long-term adverse drug reactions (ADRs), 
which may not only affect patients’ quality of life but also 
creates greater issues of compliance and retention to medical 
care [6]. It is well understood that patients suffering from 
chronic illnesses are likely to encounter increasingly complex 
challenges, given the fact that they require indefinite long-
term treatment care. These challenges may often result in 
delayed treatment, inappropriate healthcare-seeking 
behaviors, as well as poor compliance to the treatment or even 
a decision to forego treatment [7].  
 
Lack of information and understanding about disease and 
medicines use have been reported as common factors 
affecting HIV patients’ compliance towards prescribed 
medications [8, 9]. Likewise, misunderstandings and improper 
information about ARTs could also contribute towards the 
incorrect use of medications, increasing the possibility of 
non-adherence and therapeutic failure. Conversely, patients 
with proper understanding and information on treatment are 
likely to be more compliant, maintaining the quantity and 
quality of information for patients’ decision on their 
treatment [8]. It is thus vital for all healthcare professionals 
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involved in HIV care to ensure the provision of effective and 
efficient quality information on the prescribed medications, 
and to engage with the patients on their medication-related 
issues to foster improved compliance [10].  
 
Many barriers, including mental health, substance abuse, 
beliefs and understanding towards HIV/AIDS treatment, 
treatment complexities, side effects, and lack of social 
support resulted in poor patient adherence [11, 12]. In addition, 
perceptions of necessity of treatment and concerns about 
potential ADRs, resulted in a significant decline in adherence 
over time [13]. Therefore, qualitative research is gaining more 
popularity in the medical research forefront, particularly for 
HIV/AIDS-related outcomes [14, 15] and undeniably, these 
research outcomes are fundamental for our understanding 
towards the social and behavioral aspects of HIV and AIDS 
[16]. Moreover, patients’ prospects towards disease and its 
treatment have also been noted to affect their health-related 
quality of life[17]. 
 
In Malaysia, the number of HIV/AIDS cases is on a rise but 
little is known on the patients’ beliefs about their disease, 
perceptions of the effectiveness of the treatment, and 
perceptions on severity of the side effects of ARTs. The 
current study aims to evaluate these issues through a 
qualitative investigation.   
METHODS 
Design and setting 
A qualitative “Phenomenological approach” was adopted to 
better understand the study objectives, and to explore the 
needs for future interventions. This study was conducted in 
line with the principles of Helsinki Declaration, and upon 
obtaining necessary approvals from the Medical Research & 
Ethics Committee (MREC) and Clinical Research Centre 
(CRC), Ministry of Health, Malaysia. It was then registered 
under the National Medical Research Registry (NMRR) 
database. The study site chosen was the largest referral centre 
for infectious diseases in the country, i.e. Hospital Sungai 
Buloh, to allow for access of the model of the best practice.  
The Participants 
The study participants were Malaysian adults aged 18 years 
or older, diagnosed with HIV/AIDS, and were attending 
outpatient infectious disease clinics at Hospital Sungai Buloh, 
Malaysia. All participants were provided with study 
information sheets in both Malay (National Language) and 
English languages; while, verbal information was also 
disseminated to participants on an as-needed basis. Following 
the provision of study objectives and prior to data collection, 
both written and verbal consents were obtained from all study 
participants. Fifteen participants were approached for 
interviews; there was no new information that was obtained 
at the 13th interview and hence a saturation point was believed 
to have been achieved at this point. This number also fulfils 
the required sample size for phenomenological approaches. 
[18] 
Study Tool 
For the purpose of data collection, a semi-structured 
interview guide was developed after an extensive literature 
review and discussions with experts in the field. The 
interview guide consists of possible questions to assess the 
patients’ expectations, understandings and experiences with 
ARTs. Most of the questions were open-ended, as these 
questions provide maximum opportunity for expression of 
views, this will allow for a deeper understanding of the 
related issues [19, 20]. The preliminary draft interview-guide 
was discussed among the authors and was modified after a 
few rounds of discussions. However, to ensure that the set of 
questions developed were useful in the objective information 
retrieval, pilot interviews were conducted with HIV/AIDS 
patients. The draft interview guide was then modified based 
on specific probes identified during the pilot interviews. 
Procedure and Interview process 
In view of the sensitivity of the subject and socio-cultural 
context, in-depth-interviews were adopted for data 
collection[20]. Interviews were conducted in both the English 
and Malay languages (approximately 25-65 minutes each). 
All interviews were attended by the principal investigator 
along with a research assistant (to take field notes and 
facilitate the interview process), and were audio-recorded. 
Verbatim transcriptions for individual interview sessions 
were shared with the respective study participants for their 
approval. Additional information like participants’ 
demographics and relevant clinical data were also recorded 
from the participants’ clinical notes. Finally, upon receiving 
approvals for the verbatim transcriptions, the data was 
analysed with a thematic content analysis framework to aid 
in identification of the emerging categories (themes)[21]. All 
themes, initially identified by the principle investigator, were 
subjected to an independent review by an experienced 
qualitative researcher. 
RESULTS  
During the analysis, thirteen emerged themes were grouped 
into six theme clusters. Table 1 shows the thematic content 
analysis.   
 
Table 1. Thematic content analysis matrix 
Theme cluster Emerged themes 
Knowledge of HIV 
Treatment 
 
• Perceived curability of 
HIV/AIDS 
Non-Medicated ways of 
HIV management 
 
• Perceived effectiveness of 
life style changes 
• Beliefs in divine help 
 
Beliefs and understanding 
towards ARTs 
 
• Perceived effectiveness 
Reasons to start ART • Peer influence and beliefs 
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• Disease understanding and 
positive values 
 
Reasons to delay ART 
• Fear of side effects 
• Lack of support 
• Negative values 
• Delay in accepting status 
 
Experiences with ART 
• Pill burden 
• Unwanted effects 
• Impact of ADRs on well-
being 
 
Knowledge of HIV treatment 
• Perceived curability of HIV/AIDS 
Most of the patients were aware about ARTs as a treatment 
option for HIV/AIDS. They also believed that although these 
drugs may not completely cure HIV/AIDS, their lifespan may 
be increased by using these medications. Interestingly a few 
patients kept themselves updated regarding current HIV 
treatment options available globally and are hopeful that there 
will be a cure to the disease.  
“Not completely, but we can do a lot…we can do some 
treatment, so we can live longer and……. We can treat it, but 
we cannot kill the virus” (PT3). 
I think can, soon, because…. in other country they have a 
report saying they have a cure about HIV….AIDS; have two 
cases, one is a guy….but one is baby, the mother have 
HIV…….she already give the HAART, ART treatment. So 
after 3 years, the baby is fully cured…” (PT9). 
Non-medicated ways of HIV management  
• Perceived effectiveness of lifestyle 
changes 
Although they were aware that HIV/AIDS is not completely 
curable, most of the participants strongly believed that 
adopting a healthy lifestyle will somehow be beneficial in 
managing the disease.  
“I’ll just get really healthy making sure I’ve got clean water, 
clean air, I’m living an environment that’s not polluted……, 
do a lot of exercise.” (PT1) 
Positive-thinking was perceived as a way of life for some 
participants to stay healthy and boost their immune system. A 
generalised positive optimism towards healthy living played 
an important role in some of the patients’ treatment decision-
making process as they decided to forgo their modern 
medicines in treating HIV/AIDS; they merely relied on 
lifestyle changes as a cure for their disease.  
“…..I really take care of myself, like, I sleep 8 hours, I eat 
healthy food, and then always positive thinking, that practice 
make me live fifteen years without medication,… .” (PT6) 
• Beliefs in divine help 
Spiritual attributes were also closely associated with HIV, in 
which some participants were of strong opinions that besides 
taking medications and living healthily, praying to God while 
asking for forgiveness will assist in managing the disease. 
Such beliefs highlighted the greater importance of spirituality 
in the overall management of the disease among Malaysian 
HIV/AIDS patients. 
“Yes, I think, for us, as Muslim I think we believe that, there 
is a beside medication right! If you pray God, and then you 
change your lifestyle, you really…..regret whatever you did, 
and I believe anything can happen.” (PT10) 
Beliefs and understanding towards ARTs 
• Perceived effectiveness 
Most participants were grounded in their belief of the 
effectiveness of antiretroviral therapy. The patients generally 
believed that medications provided by the doctors or hospitals 
are the best treatment options for HIV that can prolong their 
life span.  
“I know ART is available, and I know that ART can be quite 
successful in many cases. I think, if I’m not mistaken there’s 
like 60% success rate, but I’m not 100% sure about…… I 
haven’t heard of any other drug…..Some have survived, some 
have not… .” (PT1) 
However, despite such viewpoints, a few were sceptical about 
the benefits of ARTs, as to them, they will eventually die 
from this disease. 
“I am going to pass away,…. some more what for want to 
take all this things? (PT12) 
Despite strong beliefs in the effectiveness of ARTs, most 
patients were concerned about the side effects and toxicities 
caused by the medications.  
“……there are drugs available, although the drugs are 
horrible. I mean, I think doctors don’t actually tell you how 
horrible these drugs can be ,……I don’t want to go on ART 
because I know that these drugs have got really horrible side 
effects,…. .” (PT1) 
Reasons to start ART  
• Peer influence and beliefs 
Most of the participants specified personal belief and strong 
influence from peers’ (HIV infected individuals) experiences 
as main contributory factors in commencing antiretroviral 
treatment. In addition, clear views and understanding of the 
disease progression, and positive patient values were also 
associated with the decision to commence antiretroviral 
treatment.  
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 “…some people say, if we don’t have… the treatment, maybe 
we can stay… 5 years or more, or 10 years. If we have 
treatment, maybe we can stay 20 years or 30 years, so it 
makes us to… .” (PT9) 
• Disease understanding and positive values 
“…..I’m not gonna let discrimination or stigma get in the way 
of my life…..” (PT1) 
 “It takes me a year and a half, after I was diagnosed. In the 
beginning yes, but I think positive... that sooner or later I need 
to take it, because it’s all about my health… .” (PT5) 
Reasons to delay ART  
• Fear of side effects 
A handful of patients delayed antiretroviral treatment due to 
potential side effects. These patients were fearful of adverse 
drug events and were sceptical on the effectiveness of these 
medications. Some patients stated that sharing of treatment 
experiences may pose a greater challenge to commence ARTs 
as such sharing may involve negative and unpleasant 
experiences too.  
“They said it was a terrible experience to have this 
ART…they have mentioned that when they use this Stocrin, 
they experience this nightmare, and…..I found scary as well 
to initiate ART at this time.”(PT2) 
 “….fears about,…..that’s why I hate people say ‘Sharing is 
Caring’…..When people talk about…..sharing about side 
effect medication, actually sharing is killing people, those 
who are newly diagnosed…”(PT4) 
• Lack of support 
Some of the patients found that the lack of support groups, 
especially in terms of treatment related issues was one of 
the reasons for treatment delays, since they don’t acquire 
the support they require. 
“… is quite difficult to find a support group, then I have to 
struggle myself, and… not much information was also 
available, so. Yeah. Not much information and those, last 
time, I have to struggle.… .” (PT4) 
• Negative values 
Negative perceptions about antiretroviral treatment and 
negative patient values also contributed to treatment delays. 
Such negative values could be accountable for a greater 
impact of HIV/AIDS on patients’ quality of life. 
“...because of the negative values inside them. They lost 
hope…There are a lot of problems, and maybe at certain 
stages, you feel you are useless and all that right, there is a 
negative value still on you because you are being diagnosed 
without notice.” (PT11) 
• Delay in accepting status  
For some patients, the sudden news of being ‘HIV positive’ 
greatly impacts a patient’s life that it eventually takes time 
before they accept their status and commence treatment. 
“I believe every people who just know they’re positive, they 
will be in shock, cannot accept and lastly, they will accept 
eventually. So, during this period…you know, different period 
they will have different barriers...” (PT2) 
“I believe every patient when they first diagnose, they don’t 
think about (treatment), they don’t think about seeing a 
doctor. The first thing that come to the mind, ‘Shit happens’ 
so now how am I going to deal with my wife, my parents? It’s 
a shock phase……..with that, for a long time to accept, and 
only after they accept it, they will, you know, ‘what option do 
I have?’ And by the time when... It is already too late, you 
know… .”(PT2) 
Experiences with ART 
• Pill Burden 
The patients shared their experiences with antiretroviral 
treatment, some of which were concerns regarding pill 
burden, both in terms of the number of tablets as well as the 
frequency of therapy. Most patients faced challenges, 
especially in the beginning of the treatment since the 
medications have to be taken on a daily basis. Of course, these 
medications are not limited to ARTs only, but include 
multivitamins, antibiotics and other medications for 
alleviation of various symptoms due to the disease. The 
patients also found it challenging to carry around and 
consume their ARTs during their routine social life, due to 
perceived stigma in the community.  
“The frequency, the scheduling of the treatment ...Yeah that’s 
what I mean. So that can be complicated in that 
sense...there’s an issue of stigma of course, you know you’re 
worried that people will find out that you’re taking all these 
drugs, and most probably you’re HIV positive……That’s the 
second thing.” (PT1) 
“….In beginning back to early stage, I have to take 5 pills at 
night and 2 pills in the morning, so altogether 7 
pills……There are other multivitamins that I have to take.” 
(PT4) 
Some patients were also of the notion that the pill burden is 
hazardous to the body. 
“I not think so lah, lot of medicine take also not good, no 
point lah…..but reduce the medicine lah, you know, cannot 
eat too much medicine also.” (PT12) 
• Unwanted effects 
Almost all patients undergoing antiretroviral treatment 
experienced unwanted adverse effects.  These reported side 
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effects range from skin rashes, nausea, vomiting, diarrhoea, 
dizziness, confusion, sleep disturbances and nightmares, 
which were intolerable and resulted in a lot of inconvenience. 
According to them, they were either given medications to 
treat these unwanted effects or were informed by their doctors 
that these are normal expected effects of the medications that 
one has to live with.  
“…The side effects are really quite bad…, the discoloration 
in your face…… especially that thing that you get on your 
face, that kind of burnt look…… One is because the treatment 
is really complicated. Another thing is the side effects is really 
terrible.” (PT1) 
“Stocrin and Combivir...make people feel want to vomit, and 
actually I have this medicine for one month, and every day I 
feel want to vomit. ….It makes you feel uncomfortable.” 
(PT9) 
 “I failed the Nivirapine, a week after taking the medication; 
I failed……rash on my whole body.”(PT13) 
• Impact of ADRs on well-being 
Although some patients managed to tolerate the side effects 
of ARTs, a handful shared the devastating impact of these 
side effects on their daily routine. They perceived negative 
impacts in their physical, mental and social well-being due to 
these effects. A few even experienced suicidal thoughts and 
decided to discontinue their medications as they preferred 
faster death over the unbearable impact of ARTs.   
“ART….makes me very sad, makes me like want to suicide, 
you know, the side effect is very hard…..Is the diarrhoea, one 
in a half month, and…….my weight is going down, 52 to 46 
now,…….and then I don’t have…. freedom what to eat” 
(PT6) 
“I will feel quite suffer to have the treatment because I said I 
have the vomit (side effect) for it…., sometime I decided to 
stop the medicine, but I’m, I will scare if I stop the 
treatment…..maybe I will die faster than…..”(PT9) 
DISCUSSION 
Malaysian HIV/AIDS patients were of the mind-set that 
antiretroviral medications are the only and most effective 
available treatment for HIV/AIDS. Though these patients 
were generally unable to comprehend if HIV/AIDS is 
manageable, they were aware that ARTs can help them live 
longer. The findings are considerably reasonable as the 
patients felt that the lack of understanding and incorrect 
beliefs in antiretroviral treatment can result in improper use 
of medications and adherence issues, eventually leading to 
therapeutic failure [8, 9]. For chronic diseases, practical health 
literateness has strong connections with disease-related 
knowledge and understanding, and treatment perceptions [22]; 
hence, there is a greater need for strong beliefs and 
understanding towards ARTs. Improved understanding of 
medications facilitates the discourse between patients and 
health care professionals (HCPs), cultivates an active 
participation of the user about own health, and this positively 
influences treatment adherence and ultimately improves 
therapeutic outcomes [8].  
It is also interesting to note that strong cultural beliefs 
influenced PLWHA to resort to divine help as a solution to 
the disease. In addition, the participants believed that 
practicing a healthy lifestyle will complement their 
antiretroviral therapy outcomes. In the history of mankind, 
spirituality has a strong relationship with chronic diseases 
such as cancer, heart disease, neurological problems and 
kidney diseases [23]. Similar studies have found constructive 
outcomes of such beliefs among HIV/AIDS patients, in terms 
of improved quality of life [24] as well as slowing disease 
progression [25]. However, such cultural beliefs are often 
regarded as barriers towards adherence [9, 26].  A South African 
study identified a deeply entwined spirituality among 
PLWHA, whereby participants believed strongly in divine 
help that would permit them to live stronger and longer 
despite having HIV/AIDS[23]. These findings iterate the need 
for spiritual assessments and its implications on HIV/AIDS 
treatment program.  
In addition, although the healthy lifestyles adopted by 
patients may not directly influence their HIV treatment, it 
could have a significant impact on their overall disease 
management.  Sikkema et al. found that HIV-related 
symptoms, shame, coping style, and substance use have 
significant associations with sexual risk behaviour among 
HIV individuals, whereby enhanced coping skills could help 
in preventing these behaviours [27]. Similarly, it was also 
concluded in a study that exercise can possibly benefit HIV 
treatment by managing disease symptoms as well as ADRs 
experienced by the patients [28]. The importance of being 
aware of patients’ perceptions towards ARTs should be 
paramount in any HIV care program. In the present study, one 
of the key aspects of patients’ understanding towards 
treatment was noted as the perceived fear of side effects 
caused by antiretroviral treatment. A number of studies have 
reported negative perceptions towards ARTs that include 
ADRs as the most common cause of refusal to commence 
ARTs and non-adherence to the treatment [13, 29-35]. 
Additionally, treatment beliefs have been highlighted as an 
important factor to sexual risk behaviour [36], making 
assessments of such beliefs and perceptions extremely 
important as to which strategies should be implemented to 
improvise existing interventional programs in order to better 
manage the challenges of adherence and retention to care.  
Patients’ experience with disease and associated treatment 
was another important theme that emerged during the 
analysis. When elucidating their experiences with the disease, 
the participants identified significant impacts of HIV on their 
routine activities and overall well-being, in particular 
physical, mental and emotional well-being. In addition, 
deterioration of work efficiency and social isolation were also 
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included among such experiences by PLWHA. Such claims 
appeared analogous to a study which concluded that 
psychological and social well-being were affected more than 
physical well-being among PLWHA in Malaysia [2]. Poor 
perceived and reported HRQoL have been widely established 
and is a well-known phenomenon among PLWHA [37]. Living 
with a chronic disease such as HIV/AIDS and an ongoing 
struggle for better care definitely results in negative impacts 
and greater challenges for these individuals [7]. Penedo et al. 
concluded that personality traits were closely associated with 
quality of life among PLWHA, which in turn may affect 
treatment adherence [38]. Both disease and its treatment-
related factors could be held accountable for decreased work 
efficiency; nutritional issues of HIV/AIDS depletion of folic 
acid and vitamin B12 causes anaemia that decreases work 
endurance among PLWHA [39]. As far as social isolation is 
concerned, it is a well-known issue tagged with stigma and 
discrimination generated by the disease [15, 23, 40-42]. In line 
with the change of status in PLWHA, they require changes in 
physical health, psychological functioning, social relations, 
and adoption of disease-specific regimens throughout their 
life span [43]; hence, continuous support to them is crucial in 
managing HIV with ARTs.  
An overall positive value that includes understanding towards 
the disease and its treatment with the patients’ peer influences 
were regarded as major reasons to start ARTs. A qualitative 
exploration of Australian HIV/AIDS patients has found a 
number of reasons that resulted in treatment delay and these 
include fear of side effects; the perceived inconvenience of 
the treatment and beliefs that there was no reason to start 
therapy in the absence of AIDS-related symptoms [35]. 
Interestingly, a Polish study revealed fear of side effects as 
well as patients’ self-perceptions that they were not 
candidates for ARTs, as most prevalent reasons to delay their 
ART treatment [32].  Perceived side effects of the treatment 
alone were regarded as important factors in delaying 
treatment and it is not limited to HIV/AIDS. A recently 
published Malaysian study among Cancer patients also found 
similar reasons for the delay [44], emphasizing the need for 
greater patient and care giver discussions in explaining the 
importance of treatment. Such fears were also reported as the 
key to care failure [26, 29].  The diagnosis of diseases like 
HIV/AIDS encompasses a state of shock, sadness and guilt 
for which these patients were never prepared and such 
situations can often lead to difficulty in accepting the status 
[40].  
Although many patients believed in the effectiveness and 
need of ARTs for the management of HIV/AIDS, they shared 
their difficulties in compliance due to the pill burden, side 
effects and negative impact of ARTs on quality of life. 
Antiretroviral medications result in a range of short term and 
long term toxicities [45]. The absence of cure for HIV/AIDS 
results in a continued experience of uncomfortable side 
effects that not only decrease quality of life  [46] but also 
causes genuine issues of retention to care and long terms 
adherence [47]. A qualitative finding of psychosocial impact 
of lipodystrophy, a commonly associated side effect of ART, 
depicted that lipodystrophy had physical and psychological 
effects, ranging from bodily discomfort to low self-esteem 
and depression. The study recommended that HCPs take 
notice of such ADRs before it results in non-adherence [48]. 
Studies have reported that almost 90% of patients on HAART 
had experienced side effects [49], highlighting the importance 
of this issue to both patients as well as HCPs. The greater 
issue of adherence to ARTs have been evaluated by a number 
of quantitative studies, and ADRs have consistently been 
reported as one of the most common factors associated with 
poor adherence [50]. This highlights the importance of 
addressing the issue through multi facet approaches involving 
all HCPs. These particular experiences while highlighting the 
patients challenges, also emphasize the greater role of 
pharmacists in providing pharmaceutical care with regards to 
reducing the pill burden, and dose frequencies, and 
minimizing ADRs and drug interactions, to improve overall 
adherence and treatment outcomes [51].  
Study limitations:  
As the study took place at a hospital (clinical setting), this 
may have influenced the patients’ perceptions and views on 
the subject matter. The findings may not represent PLWHA 
who are not receiving any medical care. 
CONCLUSION 
Qualitative explorations can provide meaningful insights on 
patients’ understandings and experiences with the disease and 
associated treatment. These insights are helpful in devising 
strategies to optimise patient care. It is vital for people living 
with HIV/AIDS (PLWHA) to be retained in care. Hence, the 
provision of optimal care with greater support to overcome 
treatment challenges must be focused in any HIV program. 
Key Considerations 
• Lack of treatment understandings and misconceptions 
could lead to therapeutic challenges. 
• HIV patients have many misunderstandings towards 
ARTs, in addition their experiences with these 
medications are often not explored. 
• Qualitative methods can help explore the real 
challenges faced by HIV patients with regards to ARTs. 
• These findings could help in scrutinizing the existing 
strategies and devising effective plans towards 
medication-related issues, including adherence and 
retention to care. 
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